The 20 Best Guillain-Barre Syndrome Doctors Near Me in Maryland, US

David Cornblath is a Neurologist practicing medicine in Lutherville Timonium, Maryland. Dr. Cornblath is rated as an Elite provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Chronic Polyradiculoneuritis, Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barre Syndrome, and Miller-Fisher Syndrome.

Emily Woo is a primary care provider, practicing in General Practice in Silver Spring, Maryland. Dr. Woo is rated as a Distinguished provider by MediFind in the treatment of Guillain-Barre Syndrome. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Guillain-Barre Syndrome, Flu, Thrombocytopenia, Cor Pulmonale, and Spinal Fusion.

Dr. Pardo's interest in transverse myelitis centers on management of acute myelitis, biomarkers of the disease in cerebrospinal fluid (CSF) and blood, and the role of neuroimmune factors in the pathogenesis of myelopathies. Along with others neurologists and health care providers in the Johns Hopkins Transverse Myelitis Center, Dr. Pardo focuses on a comprehensive approach in the diagnosis and management of myelopathies, myelitis, neuroimmunological and neuroinfectious disorders. Dr. Pardo is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Acute Flaccid Myelitis (AFM), Neurosarcoidosis, Transverse Myelitis, Zika Virus Disease, and Gastrostomy. Dr. Pardo is board certified in American Board Of Psychiatry And Neurology.

Prior to joining the Mid-Atlantic Epilepsy and Sleep Center, Dr. Jonathan Ross was Director of The New England Epilepsy Institute, a division of New England Neurological Associates (NENA) in Lawrence, Massachusetts. He also served as head of the Neurology division at NENA. After graduating medical school in 1991, Dr. Ross completed postgraduate training at Harvard Medical School and Boston University School of Medicine, and also served as Teaching Fellow at Harvard and Boston University. Dr. Ross is an active member of the American Epilepsy Society, American Clinical Neurophysiology Society, Massachusetts Medical Society, and the American Academy of Neurology. Dr. Ross is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Seizures, Memory Loss, Autosomal Dominant Partial Epilepsy with Auditory Features, and Benign Rolandic Epilepsy. Dr. Ross is board certified in American Board Of Psychiatry And Neurology.

Dr. Brett Morrison specializes in neuromuscular disorders in adults including peripheral neuropathies, amyotrophic lateral sclerosis, myasthenia gravis and muscle diseases. Dr. Morrison is currently the site principal investigator for clinical trials investigating new treatments for chronic inflammatory demyelinating polyneuropathy (CIDP) and painful diabetic peripheral neuropathy. Dr. Morrison's research interests include investigations into the mechanisms of nerve regeneration and common peripheral neuropathies. Current research focuses on better understanding the role of the immune system in peripheral nerves and targeting these pathways for the development of new treatments. Dr. Brett Morrison received his M.D. and Ph.D. from Mount Sinai Medical School in New York City. He completed his medical internship at the University of Maryland and residency in neurology at The Johns Hopkins Hospital. He then completed a fellowship in Clinical Neurophysiology at The Johns Hopkins Hospital. Dr. Morrison is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, and Spinal Muscular Atrophy (SMA). Dr. Morrison is board certified in American Board Of Psychiatry And Neurology.

Dr. Tracy Friedlander is a clinical associate specializing in neurological rehabilitation at the Johns Hopkins Department of Physical Medicine and Rehabilitation. Her focus is on helping patients manage spasticity (a muscle control disorder) through a variety of treatment approaches. Dr. Friedlander graduated from Emory University in Atlanta, GA, and earned her medical degree at the University of Maryland School of Medicine. She interned at Mercy Medical Center and completed her residence in physical medicine and rehabilitation at Sinai Hospital of Baltimore. Videos Dr. Tracy FriedlanderNeurological Rehabilitation Selected Publications Henrikson CA , Howell EE , Bush DE , Miles JS , Meininger GR , Friedlander T , Bushnell AC , Chandra-Strobos N. Prognostic usefulness of marginal troponin T elevation. The American Journal of Cardiology. 2004 Feb; 93(3): 275-279. Henrikson CA , Howell EE , Bush DE , Miles JS, Meininger GR , Friedlander T , Bushnell AC , Chandra-Strobos N. Chest pain relief by nitroglycerin does not predict active coronary artery disease. Annals of Internal Medicine. 2003 Dec; 139(12): 979-986 Courses & Syllabi Inpatient Rehabilitation of Spinal Cord Injury, Johns Hopkins University. Dr. Friedlander is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Hemiplegia, Miller-Fisher Syndrome, Guillain-Barre Syndrome, and Spasticity. Dr. Friedlander is board certified in American Board Of Physical Medicine And Rehabilitation.

Dr. Bipasha Mukherjee-Clavin is an Assistant Professor of Neurology in the Johns Hopkins University School of Medicine. She cares for patients with neuromuscular disorders, with a special focus on patients with peripheral neuropathy, immune-mediated neuropathy, and inherited neuropathy (also known as Charcot-Marie-Tooth disease). She sees patients in the Johns Hopkins Peripheral Nerve and multidisciplinary Charcot-Marie-Tooth clinics, and performs electromyography in the Johns Hopkins EMG lab. As a stem cell biology-trained scientist, Dr. Mukherjee-Clavin's research is focused on the use of patient-derived induced pluripotent stem cells to model genetic Schwann cell and peripheral nerve disorders to undercover novel pathways and potential treatments. During her PhD she published one of the first studies of CMT1A using patient derived stem cells (Comparison of three congruent patient-specific cells types for the modelling of a human genetic Schwann-cell disorder. Nature Biomedical Engineering. volume 3, pages 571–582 (2019)). In 2022, she was awarded the Passano award, given to a promising early career physician-scientist in the Johns Hopkins University School of Medicine. Dr. Mukherjee-Clavin completed her undergraduate studies at the University of California, Berkeley. She then completed her MD/PhD degrees, Neurology residency, and clinical Neuromuscular fellowship in the Johns Hopkins University School of Medicine. She joined the Johns Hopkins Neurology faculty in 2022. Dr. Mukherjee is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Charcot-Marie-Tooth Disease, Guillain-Barre Syndrome, Miller-Fisher Syndrome, and Chronic Polyradiculoneuritis. Dr. Mukherjee is board certified in American Board Of Psychiatry And Neurology.

Dr. R. Samuel Mayer is an associate professor of physical medicine and rehabilitation at the Johns Hopkins University School of Medicine. His clinical interests include complications of critical illness, spine disorders, pain management, disorders of muscle tone and cancer rehabilitation. Dr. Mayer serves as the director of cancer rehabilitation, director of undergraduate medical education and residency program director for the Department of Physical Medicine and Rehabilitation. He graduated from the honors program in medical education at Northwestern University School of Medicine and completed his residency in physical medicine and rehabilitation at Rush Medical College. He was chair of the Committee on Medical Education for the American Medical Student Association while he was a medical student. After completing his residency, he remained on faculty at Rush Medical College, eventually becoming the residency program director and acting chair of the Department of Physical Medicine and Rehabilitation. He joined the Department of Physical Medicine and Rehabilitation at Johns Hopkins in 2001. Dr. Mayer serves as director of the Medical Student Summer Clinical Experience in Physical Medicine and Rehabilitation for the Association of Academic Physiatrists. He is Editor in Chief of Knowledge NOW, the American Academy of Physical Medicine and Rehabilitation's online encyclopedia of the field. In 2014, he was named Distinguished Clinician by the American Academy of Physical Medicine and Rehabilitation. Dr. Mayer is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Pediatric Low-Grade Glioma (pLGG), Hemiplegia, Miller-Fisher Syndrome, and Guillain-Barre Syndrome. Dr. Mayer is board certified in American Board Of Physical Medicine And Rehabilitation.

Neurologist Susanne Muehlschlegel is an internationally known clinician-researcher who specializes in critically ill patients as well as understanding and improving shared decision-making and the ways physicians derive and convey health care recommendations and prognostication to families of neuro-critically ill patients. Her empirical family- and patient-centered research intersects with decision-science, qualitative and mixed-methods research, neurology, neurosurgery, and critical care medicine. She strongly believes that involving families and other stakeholders in her research will positively impact the clinical care of neurocritically ill patients. More about her research: Muehlschlegel Lab Dr. Muehlschlegel earned her medical degree at Philipps-University in Marburg, Germany. She completed an internship in internal medicine followed by residency training at Shands Hospital and Malcolm Randall Veteran Affairs Medical Center at the University of Florida College of Medicine. She finished her fellowship training in neurocritical care at the Harvard Combined Program at Massachusetts General Hospital and Brigham and Women’s Hospital, and she obtained her master’s degree in public health at the Harvard School of Public Health. She is the co-chair of a large international guideline on neuroprognostication, a joint guideline between the Neurocritical Care Society and the German Society for Neuro-Intensive Care Medicine (Deutsche Gesellschaft für Neurointensivmedizin). She served as the leader of the “Curing Coma” Common Data Elements subgroup for “Goals of Care Decisions / Family Data” with national and international group members. She also served as co-chair of the NIH/NINDS-funded Family Experience Workshop after Cardiac Arrest and Severe Neurotrauma. Dr. Muehlschlegel is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Traumatic Brain Injury, Subarachnoid Hemorrhage, Stroke, Craniectomy, and Gastrostomy. Dr. Muehlschlegel is board certified in American Board Of Psychiatry And Neurology and United Council For Neurological Subspecialties.

Dr. Michael Polydefkis focuses on neuromuscular diseases, particularly peripheral nerve diseases. He has a special interest in diabetic and HIV-associated peripheral neuropathy. His expertise includes nerve conduction studies, electromyography and nerve, skin and muscle biopsy reading. Dr. Michael Polydefkis received his medical degree from The Johns Hopkins University School of Medicine. He then became a Howard Hughes Medical Institute research fellow before returning to Johns Hopkins to complete an internship and residency in internal medicine, residency in neurology and a fellowship in neuromuscular diseases. Dr. Polydefkis is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Transthyretin Amyloidosis, Familial Transthyretin Amyloidosis, Primary Amyloidosis, and Peripheral Neuropathy.

Neil Porter is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Porter is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Myasthenia Gravis, Mononeuritis Multiplex, Multiple Mononeuropathy, Riboflavin Transporter Deficiency Neuronopathy, and Gastrostomy.

Peter Jin is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Jin is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal Muscular Atrophy (SMA), and Gastrostomy.

Richard Choi is a Neurologist practicing medicine in Glen Burnie, Maryland. He has been practicing medicine for over 18 years. Dr. Choi is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Stroke, Apoplexy, Subarachnoid Hemorrhage, Stent Placement, and Transmyocardial Revascularization.

Dr. Erik Hoyer is an associate professor of physical medicine and rehabilitation at the Johns Hopkins University School of Medicine. His clinical interests include inpatient rehabilitation, musculoskeletal and neurological rehabilitation, injection procedures to manage abnormal muscle tone (spasticity), and electrodiagnostic medicine (EMG). As the vice chair for quality, safety and service, he leads efforts to improve patient safety and care at Johns Hopkins, including an initiative called activity and mobility promotion (AMP) to get patients up and moving following surgery. Dr. Erik Hoyer graduated summa cum laude and received his master's degree in computer science from Brandeis University prior to graduating from the Sackler School of Medicine in Tel Aviv, Israel. He completed his internship in internal medicine at North Shore University Hospital in Manhasset, New York, and subsequently finished his residency in physical medicine and rehabilitation from Johns Hopkins University. He excelled during his residency, receiving the Hopkins Healer Award twice, and was selected as a trainee to the Rehabilitation Medicine Scientist Training Program. Dr. Hoyer’s research interests include quality improvement, implementation science, and health services research focused on improving outcomes for hospitalized patients. Dr. Hoyer is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. His clinical expertise encompasses Guillain-Barre Syndrome, Miller-Fisher Syndrome, Stroke, and Subdural Hematoma. Dr. Hoyer is board certified in American Board Of Physical Medicine And Rehabilitation.

Luke Kao is a Neurologist practicing medicine in Columbia, Maryland. Dr. Kao is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Distal Median Nerve Dysfunction, Common Peroneal Nerve Dysfunction, Morton Neuroma, and Neuralgia. Dr. Kao is board certified in American Board Of Psychiatry And Neurology.

Alba Azola, M.D., is a rehabilitation physician helping patients restore function and movement after an injury or illness. Her expertise includes neurorehabilitation and rehabilitation for swallowing disorders. Dr. Azola completed her residency in physical medicine and rehabilitation at the Johns Hopkins Department of Physical Medicine and Rehabilitation, where in her final year she was awarded the Frank L. Coulson, Jr. Award for Clinical Excellence. Prior to the residency, she was a post-doctoral fellow at the Swallowing Neurophysiology Laboratory at Johns Hopkins. Dr. Azola received her medical degree from the Ponce School of Medicine in Puerto Rico, where she grew up. After the devastating hurricane Maria in 2017, she returned to her homeland to help with hurricane relief. Dr. Azola is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. Her clinical expertise encompasses Guillain-Barre Syndrome, Miller-Fisher Syndrome, Stroke, Endoscopy, and Gastric Bypass. Dr. Azola is board certified in American Board Of Physical Medicine And Rehabilitation.

Dennis Dey, MD, specializes in neurology and is board certified in neurology and pain medicine by the American Board of Psychiatry and Neurology. He practices at UPMC Western Maryland Neurology and Proactive Pain and Neurology. Dr. Dey completed his fellowship at Massachusetts General Hospital - Harvard Medical School, residency at MCP Hahnemann University/Drexel and Universitats Augenklinik, and medical education at Freie Universitat Berlin. Dr. Dey is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Cervical Spondylosis, Stroke, Headache, and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Dr. Dey is board certified in American Board Of Psychiatry And Neurology and American Board Of Psychiatry And Neurology.

Dr. Ahmet Hoke is Professor of Neurology and Neuroscience, W. W. Smith Charitable Trust Professor of Neuroimmunology at Johns Hopkins School of Medicine, Director of the Daniel B. Drachman Division of Neuromuscular Diseases and Director of the Merkin Peripheral Neuropathy and Nerve Regeneration Center at Johns Hopkins University School of Medicine. He completed his medical training at Hacettepe University School of Medicine in Ankara, Turkey followed by his PhD studies in developmental neuroscience at Case Western Reserve University in Cleveland, Ohio, and neurology residency at Johns Hopkins Hospital. After completing his neuromuscular training at University of Calgary, Canada, he returned to Johns Hopkins University as faculty and rose through the ranks. He is the recipient of several awards including Derek Denny Brown Young Neurological Scholar Award (2005) and Wolfe Neuropathy Research prize (2018) given by the American Neurological Association, Myung Memorial Lecture Award (2017) by the Korean Neurological Association, Nejat Eczacibasi Medical Scientist Award (2019) by the Eczacibasi Foundation, Turkey, and Alan J. Gebhart Prize in Excellence in Neuropathy Research (2022) by the Peripheral Nerve Society. He is an Ex-Officio member of the Board of Directors of the American Neurological Association, and Vice-President of the Toxic Neuropathy Consortium. He serves on several editorial boards and is the Editor-in-Chief of Annals of Clinical and Translational Neurology. Dr. Hoke is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Wallerian Degeneration, Peripheral Neuropathy, Tomaculous Neuropathy, Spinal Muscular Atrophy with Arthrogryposis, and Prostatectomy. Dr. Hoke is board certified in American Board Of Psychiatry And Neurology.

Dr. David Hale is a fellowship-trained neurologist specializing in neuro-visual and vestibular disorders. He diagnoses and treats patients with symptoms including dizziness, vertigo, oscillopsia, double vision and imbalance. Dr. Hale’s patient evaluations include vestibular testing. Dr. Hale earned his medical degree at Pennsylvania State University and completed a neurology residency at the Johns Hopkins University School of Medicine. He remained at Johns Hopkins for fellowship training in vestibular and ocular-motor oto-neurology. Dr. Hale is interested in resident and fellow medical education, specifically the development of ways to make knowledge of subspecialist neurologists more accessible to those in training. He serves as the co-director of the Vestibular and Ocular-Motor Oto-Neurology Clinical Fellowship at Johns Hopkins. Dr. Hale is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. His clinical expertise encompasses Brown Syndrome, Vertigo, Chronic Polyradiculoneuritis, and Guillain-Barre Syndrome. Dr. Hale is board certified in American Board Of Psychiatry And Neurology.

Frederick Nahm is a Neurologist practicing medicine in Columbia, Maryland. Dr. Nahm is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Cervical Myelopathy, Dysembryoplastic Neuroepithelial Tumors (DNET), Brain Stem Cancer, and Invertebral Disc Disease. Dr. Nahm is board certified in American Board Of Psychiatry And Neurology Neurology and American Board Of Electrodiagnostic Medicine.